MARTYN D GREENACRE
CIK 1209727 · last filed 2026-07-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$314
Companies
7
Total Filings
59
Lifetime Open-Market Net
-$3.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRIS | Director | 65 | $4.83 | $314 | -$874.1K | 27 | 2026-07-09 |
| LISATA THERAPEUTICS, INC. (NBS) Delisted | Director | 88,531 | — | — | $0 | 4 | 2015-06-04 |
| LISATA THERAPEUTICS, INC. (NBS.WS) Delisted | Director | 755,306 | — | — | $0 | 3 | 2012-07-03 |
| CEPHALON INC (CEPH) Delisted | Director | 10,000 | — | — | -$3.03M | 11 | 2011-10-17 |
| BMP Sunstone CORP (BJGP) Delisted | Director | 17,800 | — | — | $19.8K | 6 | 2009-08-17 |
| ACUSPHERE INC (ACUS) Delisted | Director | 135,062 | — | — | $25.7K | 6 | 2009-01-06 |
| ORCHESTRA THERAPEUTICS, INC. (FLE) Delisted | Director | — | — | — | $0 | 1 | 2007-04-30 |
Recent Filings · Page 2 of 6
59 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-24 | CRIS | Grant (A) | +185,000 | $0 | EDGAR |
| 2017-06-02 | CRIS | Mixed | +2,807 | -$0 | EDGAR |
| 2017-03-02 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2016-05-27 | CRIS | Mixed | — | -$300 | EDGAR |
| 2016-01-21 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2015-06-04 | LISATA THERAPEUTICS, INC. (NBS) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2015-01-28 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2015-01-02 | LISATA THERAPEUTICS, INC. (NBS) Delisted | Grant (A) | +14,000 | $0 | EDGAR |
| 2014-01-28 | CRIS | Grant (A) | — | $0 | EDGAR |
| 2014-01-03 | LISATA THERAPEUTICS, INC. (NBS) Delisted | Grant (A) | +14,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.